IMMUNOMEDICS INC (IMMU)
Institutional ownership reported to the SEC as of Q3 2021, across 9 quarters.
1
Reporting holders
$15.0K
Reported value
0.0%
Held as options
-415
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| Neo Ivy Capital Management | $15.0K | 430 | 0.02% | new | NEW |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q3 2021 | 1 | $15.0K | 430 | 1 | 0 | 0 | 0.0% |
| Q3 2020 | 416 | $18.0B | 203,923,526 | 157 | 85 | 135 | 3.8% |
| Q2 2020 | 318 | $7.6B | 207,723,451 | 116 | 89 | 80 | 3.3% |
| Q1 2020 | 226 | $2.5B | 180,434,433 | 32 | 75 | 66 | 1.8% |
| Q4 2019 | 252 | $3.8B | 175,090,941 | 48 | 79 | 65 | 3.5% |
| Q3 2019 | 212 | $2.3B | 163,599,045 | 29 | 75 | 56 | 4.6% |
| Q2 2019 | 208 | $2.5B | 173,371,412 | 25 | 85 | 49 | 5.3% |
| Q1 2019 | 216 | $3.5B | 175,450,448 | 50 | 70 | 57 | 2.5% |
| Q4 2018 | 211 | $2.6B | 164,178,816 | 5 | 6 | 4 | 9.2% |